{
    "Trade/Device Name(s)": [
        "AssureTech Panel Dip Tests",
        "AssureTech Quick Cup Tests"
    ],
    "Submitter Information": "Assure Tech. Co., Ltd.",
    "510(k) Number": "K170049",
    "Predicate Device Reference 510(k) Number(s)": [
        "K142396"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NFT",
        "NFW",
        "NFY",
        "NGG",
        "NGL",
        "NFV",
        "PTH",
        "NGM",
        "PTG"
    ],
    "Summary Letter Date": "May 2, 2017",
    "Summary Letter Received Date": "March 24, 2017",
    "Submission Date": "March 18, 2017",
    "Regulation Number(s)": [
        "21 CFR 862.3100",
        "21 CFR 862.3870",
        "21 CFR 862.3250",
        "21 CFR 862.3610",
        "21 CFR 862.3650",
        "21 CFR 862.3170",
        "21 CFR 862.3150",
        "21 CFR 862.3620"
    ],
    "Regulation Name(s)": [
        "Amphetamine test system",
        "Cannabinoids test system",
        "Cocaine and cocaine metabolites test system",
        "Methamphetamine test system",
        "Morphine test system",
        "Benzodiazepine test system",
        "Barbiturate test system",
        "Methadone test system",
        "Opiate test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamine",
        "Oxazepam",
        "Cocaine",
        "Cannabinoids",
        "Methamphetamine",
        "Morphine",
        "Oxycodone",
        "Secobarbital",
        "Buprenorphine",
        "Methylenedioxy-methamphetamine",
        "Phencyclidine",
        "Methadone"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [
        "Urine collection cup"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Competitive binding",
        "Lateral flow immunochromatographic assay"
    ],
    "Methodologies": [
        "Immunochromatographic assay",
        "Lateral flow"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay",
        "Cup",
        "Dip card"
    ],
    "Document Summary": "FDA 510(k) summary for AssureTech Panel Dip Tests and AssureTech Quick Cup Tests for qualitative detection of multiple drugs of abuse in urine using lateral flow immunochromatographic assay.",
    "Indications for Use Summary": "Qualitative and simultaneous detection of multiple drugs of abuse (including amphetamine, oxazepam, cocaine, cannabinoids, methamphetamine, morphine, oxycodone, secobarbital, buprenorphine, methylenedioxy-methamphetamine, phencyclidine, methadone) in human urine for over-the-counter and prescription use.",
    "fda_folder": "Toxicology"
}